Akebia Therapeutics
AKBA
#9606
Rank
โ‚น9.91 B
Marketcap
โ‚น35.72
Share price
-8.71%
Change (1 day)
-74.67%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: โ‚น9.91 Billion

As of November 2026 Akebia Therapeutics has a market cap of โ‚น9.91 Billion. This makes Akebia Therapeutics the world's 9606th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น9.91 B-74.92%
2025โ‚น39.54 B8.35%
2024โ‚น36.49 B87.68%
2023โ‚น19.44 B121.4%
2022โ‚น8.78 B-70.16%
2021โ‚น29.43 B-0.56%
2020โ‚น29.59 B-46.03%
2019โ‚น54.83 B21.33%
2018โ‚น45.19 B0.71%
2017โ‚น44.88 B65.54%
2016โ‚น27.11 B2.98%
2015โ‚น26.32 B75.19%
2014โ‚น15.02 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Akebia Therapeutics was reported to be:

โ‚น9.91 Billion
by Nasdaq info icon info icon
โ‚น9.91 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น60.331 T 608,185.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น26.332 T 265,392.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น21.834 T 220,045.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚น95.74 B 865.33%๐Ÿ‡บ๐Ÿ‡ธ USA